[Expert opinions on clinical application of interferon-γ release assay of Mycobacterium tuberculosis (2021 edition)].

" issued by Chinese Society for Tuberculosis, Chinese Medical Association, it was revised and improved according to the latest developments and clinical experience, and the expert opinions were presented in six parts: principles and technical advances, quality control, application of latent tuberculosis infection diagnosis, auxiliary diagnosis of active tuberculosis, application in special populations, and the influence of common drugs on IGRA results, with a view to providing guidance for the clinical application of IGRA in China.